Oral Excipients

Abstract Ivermectin (IVM) is a widely used antiparasitic agent and has been repurposed for the treatment of COVID-19. However, its...

Abstract Hypothesis Oral delivery of the proliferation-inhibiting brain acid-soluble protein 1 effector domain peptide (Myr-NT) towards MYC-dependent gastrointestinal tumors can...

Abstract Background: D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS), an amphiphilic derivative of natural vitamin E, functions as both a drug efflux...

Abstract Gluten and soy allergies are significant health concerns, particularly in individuals with celiac disease or soy sensitivity. While dietary...

Abstract Background/Objectives. Central nervous system (CNS)-related diseases such as Alzheimer’s and Parkinson’s, Attention Deficit Hyperactive Disorder (ADHD), stroke, epilepsy, and migraines...

Advances in Pharmaceutical Product Development See the new book, edited by Keerti Jain and Awesh K. Yadav. This book discusses...

Abstract Gefitinib (GB), an oral tyrosine kinase inhibitor suffers major setbacks in clinical application due to limited aqueous solubility leading...

Introduction Neusilin Self-emulsifying drug delivery systems (SEDDS) have emerged as a promising approach for enhancing the oral bioavailability of challenging...

Abstract Mesoporous silica carriers are known to improve the solubility and bioavailability of poorly soluble Class II drugs. However, most...

Powered By Innovation, Driving Health, Wellness & Healing The building of a “best in class” solutions provider starts with understanding...